In this setting Magro et al identified a cut-off value of AFP >25.5 ng/mL at the time of LT, and an increase greater than 20.8% on the waitlist, as significant predictors of HCC recurrence following LT.16 The gene discussed is AFP; the disease is hepatocellular carcinoma.